相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Downregulation of CD24 suppresses bone metastasis of lung cancer
Hinako Okabe et al.
CANCER SCIENCE (2018)
Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma
Sang-Ah Han et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
CD69: from activation marker to metabolic gatekeeper
Danay Cibrian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2016)
CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro
Zhen Pei et al.
ONCOLOGY REPORTS (2016)
Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
Wu Luo et al.
ONCOTARGET (2016)
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias
Giovanna Carra et al.
ONCOTARGET (2016)
Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation
Chih-Ru Lin et al.
FASEB JOURNAL (2015)
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
L. Kalmanti et al.
LEUKEMIA (2015)
CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
Mi Jeong Kwon et al.
PLOS ONE (2015)
The Leukocyte Activation Receptor CD69 Controls T Cell Differentiation through Its Interaction with Galectin-1
Hortensia de la Fuente et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation
Chie Ishikawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB
Chie Ishikawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
Yueh-Lun Lee et al.
PLOS ONE (2013)
Is CD69 an effective brake to control inflammatory diseases?
Roberto Gonzalez-Amaro et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Clinical significance of CD24 as a predictor of bladder cancer recurrence
Chunxiao Liu et al.
ONCOLOGY LETTERS (2013)
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study
Giovanni Del Poeta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer
Ning Su et al.
MOLECULAR CANCER (2012)
Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34+ cells via modulation of NF-κB signalling
Jee-Yeong Jeong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Further phenotypic characterization of the primitive lineage-CD34+CD38-CD90+CD45RA-hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia
D. Wisniewski et al.
BLOOD CANCER JOURNAL (2011)
c-Jun Blocks Cell Differentiation but not Growth Inhibition or Apoptosis of Chronic Myelogenous Leukemia Cells Induced by ST1571 and by Histone Deacetylase Inhibitors
Hue-Mei Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
BCR-ABL in chronic myelogenous leukemia - How does it work?
John M. Goldman et al.
ACTA HAEMATOLOGICA (2008)
The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia
Oliver Hantschel et al.
MOLECULAR ONCOLOGY (2008)
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells
Takeshi Kawano et al.
CANCER RESEARCH (2007)
Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24
Tsuyoshi Fukushima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
Hardik Modi et al.
BLOOD (2007)
JAK1 N-terminus binds to conserved Box 1 and Box 2 motifs of cytokine receptor common β subunit but signal activation requires JAK1 C-terminus
Huei-Mei Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface
BA Vance et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
CD69 is an immunoregulatory molecule induced following activation
D Sancho et al.
TRENDS IN IMMUNOLOGY (2005)
MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation
R Nawata et al.
ONCOGENE (2003)
Erythroid gene suppression by NF-κB
JJ Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enhanced antitumor immunity in mice deficient in CD69
E Esplugues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
G Kristiansen et al.
BRITISH JOURNAL OF CANCER (2003)
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells
S Pisegna et al.
JOURNAL OF IMMUNOLOGY (2002)
A model of human p210bcr/ABL-mediated chronic myelogenous leukemia by transduction of primary normal human CD34+ cells with a BCR/ABL-containing retroviral vector
RC Zhao et al.
BLOOD (2001)
分享论文
